Confirm delete?

Bertin Bioreagent
All categories
Contact Us
You are here :

JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide

  • Zoom
    JWH 019 N-<wbr/>(6-<wbr/>hydroxyhexyl) β-<wbr/>D-<wbr/>Glucuronide
  • JWH 019 N-<wbr/>(6-<wbr/>hydroxyhexyl) β-<wbr/>D-<wbr/>Glucuronide
Cat No: 11466
Biochemicals - Drugs Of Abuse
Price is excluding VAT and does not include packaging neither shipping

JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide is an ex...


This article is not for sale online.
Contact us for more information about this article.

Territorial Availability: Available through Bertin Technologies only in France
Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.
Special Advice: Please check regulation status before ordering; additionel fees can apply.
  • (2S,3S,4S,5R,6R)-6-((6-(3-(1-naphthoyl)-1H-indol-1-yl)hexyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Correlated keywords:
  • cannabinoids receptors CB1 CB2 cannabimimetics analogs urinary metabolites forensics JWH019 JWH-019 JWHs 019 cannabinoids CBs central peripheral urine metabolism analytical reference standards neurosciences
Product Overview:
JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide is an expected major urinary metabolite of JWH 019, based on the metabolism of similar cannabimimetics.{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Size 1 mg
Shipping dry ice
CAS Number 1630023-00-5
Molecular Formula C31H33NO8
SMILES O=C(C1=CN(CCCCCCO[C@@H]2O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]2O)C3=C1C=CC=C3)C4=C5C(C=CC=C5)=CC=C4
Molecular Weight 547,6
Formulation A crystalline solid
Purity ≥98%
Custom Code 2922.19
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : JWH 019 N-<wbr/>(6-<wbr/>hydroxyhexyl) β-<wbr/>D-<wbr/>Glucuronide There are 5 products.